-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Imatinib Mesylate in Pulmonary Arterial Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Imatinib Mesylate in Pulmonary Arterial Hypertension report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Imatinib Mesylate in Pulmonary Arterial Hypertension Drug Details: Imatinib...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GP-2250 in Metastatic Adenocarcinoma of The Pancreas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GP-2250 in Metastatic Adenocarcinoma of The Pancreas report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.GP-2250 in Metastatic Adenocarcinoma of The Pancreas Drug Details:GP-2250 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Camidanlumab Tesirine in Refractory Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Camidanlumab Tesirine in Refractory Acute Myeloid Leukemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Camidanlumab tesirine in Refractory Acute Myeloid Leukemia Drug...
-
Product Insights
Glucose Monitoring Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Glucose Monitoring Pipeline Market Report Overview Glucose monitoring devices are used for time-defined or continuous measurement of blood glucose. Glucose monitoring does not include devices for ketone body testing or of any other blood constituents other than glucose. The Glucose Monitoring pipeline market research report provides comprehensive information about the Glucose Monitoring pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Key Segments ·      Continuous...
-
Company Profile
Tenax Therapeutics Inc – Company Profile
Tenax Therapeutics Inc (Tenax) is a pharmaceutical company that develops and commercializes a portfolio of novel therapeutic products for serious cardiovascular and pulmonary diseases. The company's lead product includes levosimendan(TNX-103), a calcium sensitizer developed for the treatment of patients with pulmonary hypertension associated with heart failure with PH-HFpEF. It also develops imatinib (TNX-201), a tyrosine kinase inhibitor, for the treatment of chronic myeloid leukemia. The company offers products in capsule and solid dosage forms. It partners with pharmaceutical companies to...
Add to Basket -
Product Insights
Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Hypertension, also referred to as high blood pressure, is a condition in which the arteries have persistently elevated blood pressure. The Hypertension pipeline market research report provides comprehensive information on the therapeutics under development for Hypertension, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases....
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – imatinib mesylate
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry imatinib mesylate Drug Details Imatinib mesylate is under development for the treatment of pulmonary...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – imatinib mesylate
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry imatinib mesylate Drug Details Imatinib mesylate is under development for the treatment of acute...
-
Product Insights
Respiratory Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Respiratory devices facilitate breathing during respiratory failure and other respiratory disease conditions. This category is further segmented into positive airway pressure devices, non-invasive ventilation masks & circuits, humidifiers, oxygen concentrators, oxygen conservers, ventilators, nebulizers, and respiratory device accessories. The respiratory devices pipeline market research report provides comprehensive information about the respiratory devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Product Insights
Pulmonary Arterial Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Pulmonary arterial hypertension pipeline market research report provides comprehensive information on the therapeutics under development for Pulmonary Arterial Hypertension, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Pulmonary Arterial Hypertension and...